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Response from Drs. Majumdar and Inzucchi: Question 2:
What are some of the potential harms with tight glycemic control beyond episodes of hypoglycemia?
Question 4:
Although you cite evidence for no obvious adverse consequences on the offspring of mothers who used metformin during pregnancy, what do we know about long-term effects of fetal exposure to insulin-sensitizing agents, such as developmental outcomes and metabolic effects?
Not much, and so until more data become available, it still remains uncertain, although there have not been any obvious adverse outcomes identified. Again, one would need to weigh these concerns over those related to hyperglycemia on fetal outcomes. Certainly, it is reasonable to use diet and then the standard glucose-lowering therapy during pregnancy, namely insulin, as a next step in controlling hyperglycemia until more is known.
Response from Drs. Majumdar and Inzucchi: Question 5:
For patients with polycystic ovary syndrome (PCOS) who conceive while on metformin, is it worth continuing the metformin in hopes of preventing gestational diabetes mellitus?
That is a very good thought. Given the previous question, when a patient develops hyperglycemia during pregnancy and then chooses metformin as a treatment, we accept a reasonable tradeoff in the known risks of hyperglycemia on fetal outcomes compared with the unknown long-term consequences of metformin after fetal exposure. Even though there is little evidence for harm at this point when used for gestational diabetes, one would have to consider whether it is appropriate to subject nondiabetic patients to metformin during pregnancy for diabetes prevention unless it is clear that preventing gestational diabetes has an outcome advantage over the standard approach to diagnosing and aggressively treating gestational diabetes.
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